Nature

ESTABLISHMENT AND CHARACTERIZATION OF ADENOSINE DEAMINASE (ADA)-DEFICIENT T CELL LINES

Congenital deficiency of the purine metabolic enzyme ADA causes severe combined immunodeficiency (SCID). The profound T lymphopenia characteristic of this disease has limited direct investigation of ...
Healio

Q&A: Expanded rollout of adenosine deaminase deficiency newborn screenings recommended

Please provide your email address to receive an email when new articles are posted on . T-receptor excision circle screenings can miss cases of adenosine deaminase deficiency (ADA), which can be fatal ...
Business Wire

FDA Approves Revcovi™, a New Enzyme Replacement Therapy Developed by Leadiant Biosciences, for the Treatment of ADA-SCID in Pediatric and Adult Patients

GAITHERSBURG, Md.--(BUSINESS WIRE)--Leadiant Biosciences, Inc. today announced that the Food and Drug Administration (FDA) has granted approval to Revcovi™ (elapegademase-lvlr) injection in the U.S.
Healio

Newborn screening strategy identifies otherwise missed adenosine deaminase deficiencies

Please provide your email address to receive an email when new articles are posted on . Including tandem mass spectroscopy in newborn screenings to identify adenosine deaminase deficiencies could save ...
Monthly Prescribing Reference

Revcovi Approved for Adenosine Deaminase Severe Combined Immune Deficiency

The FDA approval was supported by data from 2 multicenter, open-label clinical trials (Study 1 [N=6] and Study 2 [N=4]) Leadiant Biosciences announced that the Food and Drug Administration (FDA) has ...